214610 fundamentals
Key facts
MiCo BioMed Co. Ltd. engages in the development and commercialization of molecular diagnostic equipment and kits based on LabChip technology. Its product includes compact extraction equipment, genes extraction reagent, saliva sample collection kit, molecular diagnostic reagents, microfluidic lab chip, combination meters and strips, hemoglobin meters and strips, blood glucose meters and strips, microplate, immunodiagnostic reader, antibody diagnostic and antigen kit, neutralizing antibody diagnostic kit, and ELISA diagnostic kit. The company was founded on March 6, 2009 and is headquartered in Seongnam-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company